CISLEUKIN
Live / Applied — Fourth extension granted (statement of use) (as of 03 Nov 2025)
What this means for you
Not registered yet, but its 11 Nov 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97673066
- Mark type
- Stylized text
- Filed
- 11 Nov 2022
- Published for opposition
- 24 Oct 2023
- Attorney of record
- Andrew D. Skale
Goods and services
- Class 042 — Scientific and technological services: Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals
Owner
- INHIBRX BIOSCIENCES, INC., LA JOLLA, CA, US
- INHIBRX, INC., La Jolla, CA, US
- INHIBRX, INC., La Jolla, CA, US
Prosecution history
- 03 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Nov 2025 — SOU EXTENSION 4 GRANTED
- 03 Nov 2025 — SOU EXTENSION 4 FILED
- 03 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2025 — SOU EXTENSION 3 GRANTED
- 16 May 2025 — SOU EXTENSION 3 FILED
- 16 May 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Dec 2024 — SOU EXTENSION 2 GRANTED
- 02 Dec 2024 — SOU EXTENSION 2 FILED
- 02 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jun 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 May 2024 — SOU EXTENSION 1 GRANTED